NewTimeSpace
  • Home
  • Latest
  • Finance
  • IPO
  • ETF
  • Tech
  • Overseas
  • Video
  • Research
  • Search
  • Download NewTimeSpace App
    • Download App

      Download App

  • rss
  • User Login
  • 简
  • 繁
  • 简
  • 繁
  • EN
  • Home
  • Latest
  • Finance
  • IPO
  • ETF
  • Tech
  • Overseas
  • Video
  • Research
HOME ·

Drug Approval

CSPC PHARMA (01093.HK): Batoclimab injection wins China approval
Tags:
CSPC PHARMA01093.HKDrug Approval
2026-10-23
  • Finance
    ASCLETIS (01672.HK): Denifanstat US phase III doses first patient
  • Finance
    CSPC PHARMA (01093.HK): Batoclimab injection wins China approval
  • Finance
    TENNOR THERAP (06872.HK): TNP-2092 PJI trial doses first patient
  • Finance
    LOPAL TECH (02465.HK): Sells 76% of Indonesia unit for USD 31.92 mln
  • Finance
    XUNZHONG (02597.HK): Places 3.55 million new H shares at HKD 29.00
  • Finance
    BLACK SESAME (02533.HK): To cancel 1,982,200 treasury shares
  • Finance
    DOBOT (02432.HK): Trustee buys 50,000 H shares; 1.15 million held
  • Finance
    CHIFENG GOLD (06693.HK): Early board re-election after control change
  • Finance
    PW MEDTECH (01358.HK): Plans to Delist Non-Wholly-Owned Sichuan Ruijian from NEEQ
  • Research
    HK Stock Connect Daily Report: REALORD TECH Plummets 89.81% as Southbound Net Selling Reaches HK$9.218 Billion - 20261022
新時空 NewTimeSpace
Follow the official Linkedin account of NewTimeSpace to get the latest updates on finance, new stocks, ETFs and technology. Follow the official Facebook account of NewTimeSpace to get the latest updates on finance, new stocks, ETFs and technology. Follow the official X account of NewTimeSpace to get the latest updates on finance, new stocks, ETFs and technology. Follow the official YouTube account of NewTimeSpace to get the latest updates on finance, new stocks, ETFs and technology. Follow the official Instagram account of NewTimeSpace to get the latest updates on finance, new stocks, ETFs and technology.

Printed By: NewTimeSpace Media Limited

Address: 19H Maxgrand Plaza, No.3 Tai Yau Street, San Po Kong, Kowloon,HK

Email: contact@newtimespace.com

App Store
App Store QR Code
Google Play
Google Play QR Code
rss RSS API API Subscription
  • About NTS
  • Disclaimer
  • Privacy Policy
  • Publishing Principles
  • Brand Materials
  • Contact Us
  • Submission
  • Join Us
  • Tag
  • Finance FAQ
  • FAQ
  • EastMoney
  • GeLongHui
  • IPO
  • FUTU
  • FX168
  • LEJU
  • Hexun
  • NewTimeSpace
  • FINET
NewTimeSpace (newtimespace.com) is registered under Hong Kong Laws, Chapter 268 — the Local Newspapers Ordinance.
Disclaimer: All content on this website/application is the original work of NewTimeSpace. Any reproduction, reprinting, or use of the content of this website/application in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. All information provided on this website/application does not constitute any investment advice. The risks of using this website/application shall be borne by yourself.
Copyright © NewTimeSpace Media Limited All rights reserved. Trademark No. 307068079
  • Download NewTimeSpace App
    Scan QR Code
    Download App